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Abstract
Background: Ras GTPases are considered cytoplasmic proteins that must be localized to cell membranes for activation, and
there are few evidences of the presence of any Ras isoform in nuclei of eukaryotic cells.
Methodology/Principal Findings: Using conventional antibodies and inmunocytochemistry, differential centrifugation and
western blot, we have observed the putative presence of K-Ras isoform in the nuclei of fibroblasts and mesangial cells. In
order to avoid cross-reactions with other Ras isoforms, and using antibodies against K-Ras (R-3400, H3845-M01, sc-30) or
pan-Ras (05-516, OP40) in cells that only expressed the K-Ras isoform (fibroblasts obtained from H-ras2/2,N-ras2/2 mice) we
also detected some nuclear positive expression. To further probe the identity of nuclear K-Ras, we have generated K-Ras
knockout (K-ras2/2) embrionary fibroblasts by mating of K-ras+/2 heterozygote mice. Using specific antibodies, only H- and
N-Ras isoforms were observed in the cytoplasm of K-ras2/2 fibroblasts. However, both K-Ras4A and K-Ras4B positive signals
were detected by immunocytochemistry and Western blot with two commercial antibodies (sc-522 and sc-521 against each
isoforms, respectively) in both cytoplasm and nuclei from K-ras2/2 fibroblasts.
Conclusions/Significance: We show that the presence of K-Ras4B in fibroblast nuclei, already described by other authors, is
probably due to a cross-reaction of the antibody with an undetermined nucleolar protein. Although this study also shows
the possible nuclear expression of K-Ras isoform in fibroblasts or in mesangial cells, it also reveals the importance of being
cautious in these studies about distribution of protein isoforms due to some important limitations imposed by the
unspecificity of the antibodies or contaminations in cellular preparations.
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Introduction
Ras proteins control cell growth, proliferation and other aspects
of cellular biology including senescence/cell cycle arrest, differen-
tiation and survival, due to their ability to modulate transcription
[1]. The classical Ras proteins (p21 Ras: H-, K- and N-Ras),
together with M-Ras, R-Ras, Rap and Ral, are the prototype
members of the Ras subfamily that is included in the Ras
superfamily of small monomeric GTP-binding (G) proteins; this
superfamily also includes the Rho, Ran, Rab, Rac, Rheb, Arf and
Kir/ReM/Ras subfamilies [2]. p21 Ras proteins include three
closely related members with a molecular mass of ,21 KDa: H-
Ras (or Ha-Ras), K-Ras (or Ki-Ras) and N-Ras. K-Ras occurs in
two alternatively spliced forms: Ki(A)-Ras (or K-Ras4A) and Ki(B)-
Ras (or K-Ras4B), deriving from Kras-2 gene expression [2]. In
mammals, these three functional ras genes are ubiquitously
expressed in all organs and located in different chromosomes
[3–5] but expression levels may vary between different cell types.
Several lines of evidence suggest the existence of unique roles for
the three mammalian ras genes; gene targeting experiments have
demonstrated that neither H-Ras nor N-Ras function are essential
in the mouse: N-ras homozygous mutant mice grow normally [6].
In addition, disruption of H-Ras and N-Ras, individually or in
combination, reveals dispensability of both loci for mouse growth
and development [7]. In contrast, embryos homozygous for a
mutation in K-ras die between 12 and 14 days of gestation, with
foetal liver defects and evidence of anaemia [8]. Thus, K-ras is the
only member of the ras gene family essential for mouse
embryogenesis [8,9].
Signal transduction down the Ras pathway has been generally
considered to initiate at the plasma membrane. It is now clear that
the plasma membrane does not represent the only platform for
Ras signalling: genetically encoded fluorescent probes have
revealed signalling on a variety of intracellular membranes,
included the Golgi apparatus [10]. Thus, the members of the
Ras family of proteins are considered cytoplasmic proteins that
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must be localized to the plasma or other intracellular membranes
for activation, but there are only two studies showing the nuclear
presence of Ras isoforms [11,12]. Birchenall-Roberts et al. [12]
has been the first and only group to describe the presence of K-
Ras4B isoform in fibroblast nuclei.
In order to study the cellular distribution of the K-Ras isoform
and its possible function, we have generated K-Ras knock-out (K-
ras2/2) embrionary fibroblasts by culturing K-ras2/2 embryos
obtained from mating of K-Ras heterocygous mice (K-ras+/2). We
have also analyzed K-Ras cellular distribution in H-ras2/2/N-
ras2/2 fibroblasts, which only express the K-Ras isoform. In this
study we show the putative presence of K-Ras isoforms in nuclei of
human mesangial cells and fibroblasts from H-ras2/2/N-ras2/2
mice, whereas H- and N-Ras isoforms were absent. We
hypothesize that the detection of the K-Ras4B isoform in nuclei
of human fibroblasts previously described by Birchenall-Roberts et
al. [12] is probably due to cross-reaction of the antibody used
against K-Ras4B since we observed cytoplasmic and nuclear
staining in K-ras2/2 embrionary fibroblasts using the same
antibody. This experimental work puts forward the need to be
careful as well as provides useful information about antibodies
specificity in studies about Ras isoforms.
Results and Discussion
Cellular distribution of Ras isoforms was examined by
immunofluorescence analysis in a confocal microscope. H-, N-
and K-Ras isoforms are expressed in the plasma and intracellular
membranes of human mesangial cells, but nuclei from these cells
also showed positive staining for K-Ras4B isoform appearing as
dense aggregates using the sc-521 antibody, which is supposedly
specific for K-Ras4B isoforms (Figure 1). K-Ras4A staining
detected with sc-522 antibody was fainter than K-Ras4B
expression, accordingly with the fact that K-Ras4B is the
predominant splice variant [13].
To exclude the possibility of cross-reaction between anti-K-Ras
and other Ras isoforms, we assessed the expression of Ras isoforms
in fibroblasts from H-ras2/2/N-ras2/2 mice using the same
antibodies. Our results confirmed the lack of H- and N-Ras
isoforms, the presence of K-Ras4A distributed along the plasma
membrane and the expression of K-Ras4B in plasma membrane
and nuclei; these results confirm that the pattern of expression
observed in mesangial and fibroblast nuclei supposedly corre-
sponded to K-Ras (Figure 2).
The next step in our study was to reproduce the same set of
experiments in K-Ras KO fibroblasts. The absence of K-Ras
expression in K-ras2/2 fibroblasts, as well as the only expression of
K-Ras in H-ras2/2/N-ras2/2 fibroblasts was confirmed by PCR
and western blot analysis. Figure 3 shows genotypic characteriza-
tion and H-, N-, K-Ras4A and K-Ras4B isoforms expression in
Kras2/2 (Figure 3a–c) and H-ras2/2/N-ras2/2 fibroblasts
(Figure 3d–e) by DNA and RNA PCR and Western blot. The
immunofluorescence analysis showed the appearance of H-Ras,
N-Ras and both K-Ras isoforms in the plasma membranes and K-
Ras4B immunostaining in nuclei of wild type (Figure 4) and,
surprisingly, in nuclei of K-ras2/2 fibroblasts (Figure 5), with the
same pattern of what was supposed to be K-Ras4B staining that
we previously observed in H-ras2/2/N-ras2/2 fibroblasts and
human mesangial cells. The sc-522 antibody against K-Ras4A also
showed a fainter positive staining in both membranes and nuclei
from K-ras2/2 fibroblasts (Figure 5). Thus, our data clearly
demonstrates that sc-521 and sc-522 antibodies do not specifically
recognize K-Ras isoforms. K-Ras4B expression was detected by
western blot in nuclei from human mesangial cells using the sc-521
antibody. Moreover, three different antibodies directed against K-
Ras proteins (H3845-M01, sc-521, sc-522) detected K-Ras4B
expression in nuclear extracts from K-ras2/2 fibroblasts (Figure 6).
However, other antibody directed against K-Ras (R3400, Sigma)
detected its expression in nuclear fractions by western blot
(Figure 6). On the other hand, the sc-521 antibody directed
Figure 1. Immunofluorescence analysis of cellular distribution of Ras isoforms in human mesangial cells. Pictures show H-Ras, N-Ras, K-
Ras4A and K-Ras4B expression in human mesangial cells. The rhodamine red-labeled proteins are Ras isoforms, while the blue-labeled staining is
Hoechst-stained DNA. Magnification: 6306. Scale bar: 30 mm. Antibodies: H-Ras, sc-520; K-Ras4A, sc-522; K-Ras4B, sc-521; N-Ras, sc-519.
doi:10.1371/journal.pone.0008703.g001
Nuclear K-Ras Expression
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Figure 2. Immunofluorescence analysis of cellular distribution of Ras isoforms in H-ras2/2/N-ras2/2 fibroblasts. Pictures show H-Ras, N-
Ras, K-Ras4A and K-Ras4B expression in fibroblasts. The rhodamine red-labeled proteins are Ras isoforms, while the blue-labeled staining is Hoechst-
stained DNA. Magnification: 6306. Scale bar: 30 mm. Antibodies: H-Ras, sc-520; K-Ras4A, sc-522; K-Ras4B, sc-521; N-Ras, sc-519.
doi:10.1371/journal.pone.0008703.g002
Figure 3. Genotypic and protein characterization of Hras2/2,Nras2/2 and Kras2/2 fibroblasts by PCR and Western blot. (A) DNA PCR of
K-ras2/2 fibroblasts cultures; K-ras2/2 fibroblasts are identified by a 270-bp product, and wild type fibroblasts by a 360-bp product (see methods
section); mRNA (B) and protein (C) expression of Ras isoforms in K-ras2/2 fibroblasts cultures; mRNA expression of H, N, K-Ras4A and K-Ras4B
isoforms, evaluated by PCR (D), and protein expression (E) of H, N, and K-Ras isoforms, evaluated by Western blot, in Hras2/2,Nras2/2 fibroblasts. K-
Ras (1): mouse anti-human K-Ras (H3845-M01) from Abnova; K-Ras (2): mouse anti-mouse K-Ras (R3400) from Sigma.
doi:10.1371/journal.pone.0008703.g003
Nuclear K-Ras Expression
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against K-Ras4B showed a faint signal in cytosolic and nuclear
extracts from K-ras+/+ fibroblasts but it did not show a positive
signal by immunoblot in nuclear extracts from K-ras2/2
fibroblasts (Figure 6). Moreover, the sc-522 antibody against K-
Ras4A showed a positive signal in the cytosolic fraction from K-
ras2/2 fibroblasts (as we previously observed by immunostaining).
Figure 4. Immunofluorescence analysis of cellular distribution of Ras isoforms in K-ras+/+ fibroblasts. Pictures show H-Ras, N-Ras,
K-Ras4A and K-Ras4B expression) in K-ras+/+ fibroblasts. The rhodamine red-labeled proteins are Ras isoforms, while the blue-labeled staining is
Hoechst-stained DNA. Magnification: 6306. Scale bar: 30 mm. Antibodies: H-Ras, sc-520; K-Ras4A, sc-522; K-Ras4B, sc-521; N-Ras,
sc-519.
doi:10.1371/journal.pone.0008703.g004
Figure 5. Immunofluorescence analysis of cellular distribution of Ras isoforms in K-ras2/2 fibroblasts. Pictures show H-Ras, N-Ras, K-
Ras4A and K-Ras4B expression) in K-ras2/2 fibroblasts. The rhodamine red-labeled proteins are Ras isoforms, while the blue-labeled staining is
Hoechst-stained DNA. Magnification: 6306. Scale bar: 30 mm. Antibodies: H-Ras, sc-520; K-Ras4A, sc-522; K-Ras4B, sc-521; N-Ras, sc-519.
doi:10.1371/journal.pone.0008703.g005
Nuclear K-Ras Expression
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Unfortunately, the antibodies which were suitable for immuno-
fluorescence analysis did not show a good signal when used for
immunobloting, and the appropriate antibodies for western blot
detection were useless to perform immunofluorescence studies.
Tubulin, cyclin A and histone H1 expression were used as
controls to identify the purity of cytoplasmic and nuclear
preparations, respectively. However, it is almost unfeasible the
complete isolation and purification of nuclear fractions, consider-
ing the continuous nature of the nuclear envelope with the
endoplasmic reticulum (ER), and taking into account that 4–6% of
these nuclear fractions are cytoplasmic contaminations (mainly
ER) which are frequently stuck to the external nuclear membrane,
as it was early described by Puddington et al. [14]. Moreover, most
of the recent studies in the literature do not show controls for ER
contamination in their nuclear fraction. Even the isolation of
nuclear fractions by sucrose density gradient ultracentrifugation
showed similar results than with the CelLytic Nuclear Extraction
Kit, and traces of cytoplasmic contamination may be present
(although in the nuclear fractions there was almost no expression
of tubulin, which was used as purity control). Thus, it may well be
that the nuclear fractions had some contamination with ER-
associated proteins, attributing to the nucleus some Ras isoforms
present in the ER [15].
Finally, we evaluated by ELISA whether the presumed nuclear
K-Ras was able to bind Raf-RBD, Ras binding domain (active
state) or not (inactive state). Whereas Ras bound to Raf-RBD is
detected in cytoplasmic fractions (18.1560.92 luminescence
arbitrary units (LAU) vs. 7.3860.74 LAU corresponding to the
blank samples), our data shows that Ras is not bound to Raf-RBD
in nuclear extracts from human mesangial cells as LAU were
similar to those of the blank samples. In order to discard that Ras
activity was not detectable in nuclear extracts because of the
inactivity of this putative nuclear K-Ras, we also evaluated the
presence of nuclear active Ras in the tumoral cell line HeLa,
which express constitutively-active Ras. A small amount of Ras
bound to Raf-RBD was detected in HeLa nuclear extracts
(12.4961.27 LAU vs. 17.3262.42 LAU in HeLa cytoplasmic
fractions), but this detection is probably due to endoplasmic
reticulum contamination in the nuclear fractions. As a positive
control we used an extract of EGF-treated HeLa cells, and this
extract gives values over 32.7862.21 LAU. Thus, we may suggest
that if any Ras isoform is present in mesangial cells nuclei, this
putative nuclear Ras is not able to bind Raf.
Although it has been suggested that the C-terminus of K-Ras4B
acts as a nuclear localization signal [16], there are only two studies
in the literature showing the presence of any Ras isoform in nuclei
of eukaryotic cells. Immunofluorescence and electron microscopy
studies identified overexpressed H-Ras and Rap-1 in or around
nuclei of transformed cells [11,17], although the functional
significance of these findings is unknown. RRP22, a Ras-related
protein, was found in the nucleolus [18], and recently, Birchenall-
Roberts et al. [12], using confocal microscopy and biochemical
analysis, showed K-Ras4B staining in the nucleoli of human
fibroblasts suggesting a physical and functional association
between K-Ras4B and nucleolin, a pleiotropic regulator of cellular
processes. However, in the present study we have demonstrated
that the antibodies used by Birchenall-Roberts et al. (sc-521 and sc-
522) do not specifically recognize K-Ras proteins as they produce
a clear immunostaining in K-ras2/2 fibroblasts.
Thus, our study in K-Ras KO fibroblasts, as well as in
fibroblasts that only expressed the K-Ras isoform, shows that there
are no definitive evidences confirming the expression of K-Ras
proteins in the nuclei of fibroblasts, because the only study
published at the moment has been performed with an antibody
that does not recognize specifically the K-Ras4B isoform. K-Ras in
nuclei, if present, should be in its inactive form (not attached to
Raf-RBD). The confirmation of the presence of nuclear forms of
K-Ras is such an important finding for eukaryotic cells that makes
necessary to be cautious and control exhaustively all experimental
conditions.
Figure 6. K-Ras expression analysis in nuclear and cytoplasmic fractions of human mesangial cells and K-ras2/2 fibroblasts by
western blot. K-Ras (1): mouse anti-human K-Ras (H3845-M01) from Abnova; K-Ras (2): mouse anti-mouse K-Ras (R3400) from Sigma; K-Ras (3):
mouse anti-human K-Ras (sc-522) from Santa Cruz Biotechnologies. Cyclin A, histone H1 and tubulin were used as purity controls of nuclear (cyclin A,
histone H1) and cytoplasmic fractions (tubulin), respectively.
doi:10.1371/journal.pone.0008703.g006
Nuclear K-Ras Expression
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Materials and Methods
Ethics statement
Mice were kept in an aseptic atmosphere with controlled
temperature and light cycles in the facilities of the Animal
Experimentation Service of the University of Salamanca, with free
access to food and water; studies in mice were approved by the
Bioethics Committee of the University of Salamanca, and animals
were treated following the Recommendations from the Declara-
tion of Helsinki and the Guiding Principles in the Care and Use of
Animals stated in the international regulations and in the following
European and national institutions: Conseil de l9Europe (published
in the Official Daily N. L358/1–358/6, 18th December 1986),
and Spanish Government (published in Boletı´n Oficial del Estado
N. 67, pp. 8509–8512, 18th March 1988, Royal Decree Law 223/
1988, from march 14 and decree from October 13 1989, and
Boletı´n Oficial del Estado N. 256, pp. 31349–31362, 28th
October 1990).
Cell culture
We have analyzed Ras isoforms expression in different cell
types: human mesangial cells and fibroblasts; we analyzed
immortalized human mesangial cells (K18 line) which were
obtained as described by Banas et al. [19]; K-Ras KO fibroblasts
(K-ras2/2) were cultured from K-ras2/2 mouse embryos obtained
from mating of K-ras+/2 mice. Embryos, which were recovered at
day post coitum 10, were genotyped by PCR as later described,
mechanically minced and treated with trypsin-ethylenediamine-
tetraacetic acid (EDTA) 0.25% (Gibco-BRL, Cheshire, UK) for
30 min before plating. Immortalized cultures that survived crisis
after 15–20 passages were identified and cloned and their
genotypes reconfirmed by PCR analysis, as later described.
Expression of Ras protein isoforms was monitored by immuno-
blotting with specific antibodies directed against H-Ras (sc-520),
N-Ras (sc-519), K-Ras (sc-30), K-Ras 4A (sc-522), K-Ras 4B (sc-
521) from Santa Cruz Biotechnologies (Santa Cruz, CA, USA), K-
Ras (H3845-M01) from Abnova (Heidelberg, Germany) and K-
Ras (R3400) from Sigma (Madrid, Spain). At least two sets of
independently generated, immortalized fibroblast cell lines (orig-
inated from different embryos) were used for analysis of the K-
ras2/2 genotype. H-ras2/2/N-ras2/2 embrionary fibroblasts were
obtained from mice genetically deficient for H- and N-Ras
isoforms (H-ras+/2/N-ras+/2 and H-ras2/2/N-ras2/2) as previ-
ously described [7]. Embrionary fibroblasts and human epithelial
cervical cancer (HeLa) cells were grown in DMEM medium (Bio
Whittaker Labs, Rockland ME, USA) supplemented with 10%
fetal calf serum (FCS, Bio Whittaker Labs), 0.66 mg/ml penicillin
and 60 mg/ml streptomycin sulfate (Bio Whittaker Labs), in an
atmosphere of 95% air/5%CO2 at 37uC. Mesangial cells were
grown in RPMI 1640 (Bio Whittaker Labs) supplemented with
10% FCS, 1 mM L glutamine, 0.66 mg/ml penicillin, 60 mg/ml
streptomycin sulfate, 5 mg/ml insulin, 5 mg/ml transferrin and
5 ng/ml selenium, in an atmosphere of 95% air/5% CO2. Cells
were seeded in 100 mm Petri dishes (Nunc, Roskilde, Denmark)
for Western blot and Elisa assays, and in cover slips (Nunc) for
immunofluorescence studies, respectively.
Polymerase Chain Reaction (PCR)
Fibroblast genotyping was performed after DNA extraction
from cell cultures with DNA lysis buffer (50 mM Tris pH 7.5,
5mM EDTA pH 8.0, 100 mM NaCl, 1 mM dithiothreitol,
0.5 mM spermidin, and 10 mg/ml proteinase K). PCR was
carried out using the following primers: K-ras IMR393 (common
K-ras primer), 59- AGG GTA GGT GTT GGG ATA GC - 39,
K-ras IMR394 (wild type K-ras primer), 59- CTC AGT CAT TTT
CAG CAG GC - 39, and K-ras IMR395 (mutant K-ras primer), 59-
ACG AGA CTA GTG AGA CGT GC - 39. The primer set of K-
ras IMR393 and K-ras IMR395 amplify a 270-bp product in K-
ras2/2 fibroblasts, and the combination of K-ras IMR393 and K-
ras IMR394 amplify a 360-bp product in wild type fibroblasts.
Oligonucleotides were used in a 25-ml reaction mixture with 1 ml
of DNA and 2 units of Taq polymerase. In these reactions, DNA
was denatured for 3 min at 94uC and amplified for 35 cycles at
94uC for 30 s, 62.5uC for 30 s and 72uC for 30s, followed by an
elongation cycle of 72uC for 2 min, using a BioRad Thermal
Cycler. Amplified products were analyzed by electrophoresis in
1.5% agarose gels. The genotypes were subsequently confirmed by
rt-PCR with primers against K-ras4A and K-ras4B, and by western
blotting.
Total RNA was extracted and purified from cell cultures using
Tri-reagent (Molecular Research, Cincinnati, OH, USA). First-
strand cDNA was generated using M-MLV Reverse Transcriptase
and oligo(dT) as described by the manufacturer. RT-PCR was
performed using the next primers: for H-ras, 59-AAG CTT GTG
GTG GTG GGC GCT AAA GGC- 39 and 59- CTT TCA CCC
GCT TGA TCT GCT CCC TGT ACT - 39, corresponding to
positions 13 to 39 and 284 to 313 of the coding sequence; for N-
ras, 59 - CCA GGA TTC TTA CCG AAA GCA AGT GGT G-39
and 59 - CCT GTA GAG GTT AAT ATC TGC AAA TG-39,
corresponding to positions 4 to 31 and 162 to 187 on exon II; and
for K-ras, 59- AGT ACG ACC CTA CGA TAG AGG ACT
CCT-39, bp 92 to 118, 59 - CAA TCT GTA CTG TCG GAT
CTC TCT CAC C - 39, specific for K-ras4A bp 477 to 504, and
59- CTA ATG TAT AGA AGG CAT CGT CAA CAC CC - 39,
specific for K-ras4B, bp 450 to 478, of their respective coding
sequences. For GAPDH, 59- TGA AGG TCG GTG TGA ACG
GAT TTG GC - 39, and 59- CAT GTA GGC CAT GAG GTC
CAC CAC - 39. Cycling conditions for ras isoforms were 95uC for
4 min followed by 30 cycles of 94uC for 1 min, 62uC for 1 min,
and 72uC for 1 min, followed by an elongation cycle of 72uC for
10 min; and for GAPDH were 94uC for 5 min followed by 28
cycles of 94uC for 1 min, 60uC for 1 min, and 72uC for 1.5 min,
followed by an elongation cycle of 72uC for 5 min.
Immunofluorescence analysis
Cells in cover slips were fixed with 4% paraformaldehyde
(Sigma, St Louis MO, USA), washed with phosphate buffered
saline with calcium and magnesium (PBS Ca-Mg: 1mM CaCl2,
1 mM MgSO4, 0.81% ClNa, 2.6 mM PO4H2K, 4.1 mM
PO4HNa2), permeabilyzed with 0.1% Triton X-100, 0.2% BSA
and 0.5% sodium azide, quenched with NH4Cl 50 mM in PBS
Ca-Mg, blocked with 10% normal goat serum (NGS, Santa Cruz
Biotechnology, Santa Cruz CA, USA) in PBS Ca-Mg for 30 min,
and incubated during 2 hours with primary antibodies (dilution 1/
50–1/100) in PBS Ca-Mg with 2% NGS: rabbit anti-human H-
Ras (sc-520), rabbit anti-human K-Ras2A (sc-522) and 2B (sc-521)
(here referred as 4A and 4B), and rabbit anti-human N-Ras (sc-
519). According to the distributor, the antibodies used in this study
were supposed to be specific for the corresponding proteins and
guaranteed not to cross-react with each other. Blocking peptides
were also used to check the specificity of every antibody (data not
shown). Later, cells were incubated 30 min with goat anti-rabbit
Cy3 (Jackson Immunoresearch, West Grove PA, USA) (dilution 1/
1000) in PBS Ca-Mg with 2% NGS or normal donkey serum
(Sigma) in a dark chamber. Nuclei staining was performed by
5 min incubation with 2mM Hoechst 33258 (Molecular Probes) in
a dark chamber. Cover slips were mounted on slides using Prolong
gold antifade (Molecular Probes). Confocal images were made
Nuclear K-Ras Expression
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using a Zeiss Axiovert 200M microscope and a Zeiss LSM 510
confocal module, with a HeNe laser with 543-excitation for
rhodamine and Hg laser with 365-excitation for DAPI. All images
were obtained with identical parameters for intensity, pinhole
aperture, etc.
Western blot
Nuclei extracts were isolated by sucrose gradient ultracentrifu-
gation. Cells were washed twice with cold PBS, scrapped with
buffer A (250 mM sucrose, 20 mM Hepes pH 7.4, 1 mM EDTA
and protease inhibitors: 0.1 mM PMSF, 2mg/ml leupeptin, 2 mg/
ml pepstatin) and disrupted by 20 passages through a 23 gauge
needle; then cells were centrifuged at 500 g for 5 min, and the
pellet was washed with buffer I (10 mM Hepes-NaOH pH 7.9,
10 mM KCl, 1.5 mM MgCl2, 0.5 mM dithiothreitol plus protease
inhibitors); cells were again centrifuged at 500 g for 5 min and the
nuclei pellet was washed with buffer I with 0.25 M sucrose and
protease inhibitors. After another centrifugation, nuclei were
resuspended in buffer I and centrifuged at 100000 g for 1 h over a
1.8 M sucrose cushion prepared in buffer I. The nuclei pellet was
washed in buffer I without sucrose by spinning 5 min at 1000 g,
and resuspended in buffer I, 0.1% (v/v) Nonidet P-40 and
incubated at 4uC with intermittent mixing for 10 min. Nuclei was
harvested twice by 5 min spin at 500 g and washed in buffer I;
finally, nuclei was collected in nuclei storage buffer (10 mM
piperazine-N,N9-bis(2-ethanesulfonic acid) pH 7.4, 5 mM EGTA,
80 mM KCl, 20 mM NaCl, 50% glycerol, 250 mM sucrose,
1 mM dithiothreitol, 0.2 mM spermine, 0.5 mM spermidine) and
stored under liquid nitrogen.
Nuclei extracts were also obtained with the CelLytic Nuclear
Extraction Kit (Sigma): cells swell with hypotonic buffer (10 mM
HEPES, pH 7.9, 1.5 mM MgCl2 and 10 mM KCl) supplemented
with 1 mM dithiothreitol (DTT) and protease inhibitor cocktail,
then cells are disrupted with 0,6% Igepal, the cytoplasmic fraction
is removed, and the nuclear proteins are released from the nuclei
by a high salt extraction buffer (20 mM HEPES, pH 7.9, 1,5 mM
MgCl2, 0.42 M NaCl, 0,2 mM EDTA, and 25% glycerol)
supplemented with 1 mM dithiothreitol (DTT) and protease
inhibitor cocktail [20].
Protein content of nuclei and cytoplasmic extracts was
determined by the Lowry assay (Dc protein assay, BioRad,
Hercules CA, USA). Electrophoresis and blotting was performed
as previously described [21] with the following primary antibodies:
mouse anti-human K-Ras (H3845-M01, Abnova, and sc-30, Santa
Cruz Biotechnologies), mouse anti-mouse K-Ras (R3400, Sigma),
rabbit anti-human K-Ras4A (sc-522), rabbit anti-human K-Ras4B
(sc-521), rabbit anti-human H-Ras (sc-520), rabbit anti-human N-
Ras (sc-519) (dilution: 1/200), rabbit anti-human cyclin A (sc-571,
Santa Cruz Biotechnologies), goat anti-human histone H1 (sc-
8615, Santa Cruz Biotechnologies) (dilution: 1/1000) and mouse
anti-mouse tubulin (OP06) (dilution 1/1000) from Calbiochem
(San Diego CA, USA). After incubation with the corresponding
secondary antibody (goat anti-rabbit and goat anti-mouse IgG
(H+L) horseradish peroxidase (HRP) conjugated antibodies from
BioRad and donkey anti-goat from Santa Cruz Biotechnologies) at
dilutions 1/2000–1/10000, membranes were finally incubated
with a chemiluminescent reagent (ECL detection reagent,
Amersham Biosciences, Piscataway NJ, USA) and developed
signals were recorded on x-ray film (Hyperfilm, Amersham
Biosciences, Piscataway NJ, USA).
ELISA
We evaluated the presence of Ras bound to Raf-RBD (active
Ras) in nuclei of human mesangial cells and human tumoral HeLa
cells, using an ELISA method (Ras GTPase Chemi ELISA, Active
Motif, Rixensart, Belgium); this kit only detected Ras activation in
human cells. 50 mg of 4 different nuclear and cytoplasmic extracts
were analyzed. 25 mg HeLa whole cell extract (EGF treated) was
used as positive control. Chemiluminescence was read using a
luminometer (Thermo Luminoscan Ascent, Waltham MA, USA)
within 15 minutes to minimize changes in signal intensity.
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